BMP4 (bone morphogenetic protein 4)

Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells

Bone morphogenetic proteins (BMPs) - expressed in the developing retina - are known to be involved in the regulation of cell proliferation and apoptosis in several tumor entities. The objective of this study was to determine the role of the BMP4 pathway in retinoblastoma cells, which are absent in a functional retinoblastoma (RB1) gene. BMP receptors were detected in all retinoblastoma cell lin...

مقایسه تاثیر دوزهای مختلف (BMP4)Bone Morphogenetic Protein 4 و اریتروپویتین(EPO) بر تمایز سلول‌های بنیادی جنینی موش به کلنی‌های اریتروئیدی

  چکید ه   سابقه و هدف   تمایز سلول‌های بنیادی جنینی در شرایط کشت، سیستم آزمایشی را برای بررسی اثرات فرضی فاکتورهای رشد فراهم می‌کند. امروزه پیدا کردن فاکتورهای رشد و عوامل محیطی مورد نیاز برای خون‌سازی اهمیت دارد. هدف از این مطالعه مشخص کردن اثر دوزهای مختلف EPO و BMP4 بر تمایز سلول‌های بنیادی جنینی و ارزیابی تعداد و اندازه کل کلنی‌ها و تعداد کلنی‌های اریتروئیدی بود.   مواد وروش‌ها   مطالعه ان...

Bone Morphogenetic Protein-4 and Bone Morphogenetic Protein Receptors Expressions in the Adult Rat Eye

We investigated the expressions of bone morphogenetic protein-4 (BMP4) and its receptors, bone morphogenetic protein receptor IA (BMPRIA), bone morphogenetic protein receptor IB (BMPRIB) and bone morphogenetic protein receptor II (BMPRII) in the adult rat eye. Interesting differences in expression profile were observed between BMPRIA and BMPRIB in the retina. BMPRIA-like immunoreactivity (IR) w...

Fine mapping of the human bone morphogenetic protein-4 gene (BMP4) to chromosome 14q22-q23 by in situ hybridization.

Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors

Due to improved understanding of the role of bone morphogenetic protein 4 (BMP4) in an increasing number of diseases, the development of selective inhibitors of BMP4 is an attractive therapeutic option. The currently available BMP4 inhibitors are not suitable as therapeutics because of their low specificity and low effectiveness. Here, we compared newly generated anti-BMP4 llama-derived antibod...